Sanofi's controversial dengue vaccine wins FDA approval, with a raft of caveats
Sanofi’s controversial dengue vaccine, which took two decades to develop, has made it across the FDA finish line — but it wasn’t pretty. Less than a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
